Search
Thermo Fisher Scientific Inc
TMOAdd to Watchlist
464.610USD
+2.810+0.61%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
172.66BMarket Cap
25.48P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Thermo Fisher Scientific Inc is 8.40, ranking 37 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 625.00, with a high of 750.00 and a low of 533.16.
Analyst Rating
Based on
31
analysts
Buy
Current Rating
605.938
Target Price
+30.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Thermo Fisher Scientific Inc
TMO
31
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
30
Danaher Corp
DHR
26
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Thermo Fisher Scientific Inc's expected revenue for the next quarter?
Thermo Fisher Scientific Inc's expected revenue is 11.70B.
What is Thermo Fisher Scientific Inc's price target?
Analysts forecast that Thermo Fisher Scientific Inc's price target is USD 625.00, with the highest forecast at USD 750.00 and the lowest forecast at USD 533.16.
How have Thermo Fisher Scientific IncTMO's recent earnings per share performed?
The market expectation was USD 4.44, while Thermo Fisher Scientific IncTMO's earnings per share (EPS) for the previous quarter was USD 5.25. EPS for the next quarter is expected at USD 5.71.
What is the analyst rating for Thermo Fisher Scientific Inc?
Based on the ratings of Thermo Fisher Scientific Inc's stock from 31 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
